Drug Shortage Report for CELESTONE SOLUSPAN

Last updated on 2019-11-09 History
Report ID 94948
Drug Identification Number 00028096
Brand name CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name MERCK CANADA INC
Active Ingredient(s) BETAMETHASONE ACETATE BETAMETHASONE
Strength(s) 3MG 3MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR
Packaging size 1ML VIAL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-10-14
Actual start date 2019-10-11
Estimated end date 2019-11-08
Actual end date 2019-11-08
Shortage status Resolved
Updated date 2019-11-09
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-11-09 English Compare
v10 2019-11-08 French Compare
v9 2019-11-08 English Compare
v8 2019-11-04 English Compare
v7 2019-10-30 English Compare
v6 2019-10-12 English Compare
v5 2019-10-11 French Compare
v4 2019-10-11 English Compare
v3 2019-10-11 English Compare
v2 2019-09-27 French Compare
v1 2019-09-27 English Compare